UAE Cardiovascular Devices Market Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Type (Diagnostic & Monitoring Devices {ECG, Holter Monitors, Implantable Loop Recorders, Event Monitors, Others}, Surgical Devices {Pacemakers, Defibrillators, Stents, Valves, Other}), By Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), by region, and Competition 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 597.11 Million
CAGR (2026-2031)	5.81%
Fastest Growing Segment	Heart Failure
Largest Market	Abu Dhabi
Market Size (2031)	USD 837.94 Million

Market Overview

The UAE Cardiovascular Devices Market will grow from USD 597.11 Million in 2025 to USD 837.94 Million by 2031 at a 5.81% CAGR. Cardiovascular devices encompass a broad range of medical technologies designed to diagnose and treat heart and circulatory system disorders, including interventional tools like stents and rhythm management solutions such as pacemakers. The market in the UAE is primarily driven by the rising prevalence of conditions associated with lifestyle choices, such as obesity and diabetes, which necessitate advanced cardiac care. This demand is further supported by government initiatives aimed at early diagnosis and preventative healthcare. According to the Ministry of Health and Prevention, in 2024, the National Campaign for Early Detection of Hypertension benefitted 140,000 citizens and residents, highlighting the national focus on managing cardiovascular risks which directly correlates with increased utilization of diagnostic and therapeutic devices.

Despite this positive trajectory, the market faces a significant impediment regarding the high cost of advanced cardiovascular technologies which can limit accessibility for certain patient demographics. Stringent regulatory approval processes for importing innovative medical devices also pose a potential delay in market entry for new products. These economic and procedural barriers may slow the widespread adoption of the latest cardiac solutions and challenge manufacturers aiming to introduce next generation technologies to the region swiftly.

Key Market Drivers

The rising prevalence of lifestyle-related cardiovascular conditions is a primary catalyst propelling the UAE cardiovascular devices market. Sedentary behaviors, poor dietary habits, and high stress levels have accelerated the onset of heart disease among younger demographics, creating urgent demand for diagnostic and interventional tools. This shift towards earlier disease presentation necessitates a robust supply of stents, catheters, and monitoring systems to manage chronic conditions like hypertension and coronary artery disease effectively. According to The National News, September 2025, in the "UAE doctors warn work stress and bad diets are raising heart disease risk in under 50s" article, data from Medcare hospitals revealed that out of 11,631 cardiology outpatients in 2024, a significant 9,817 were aged 45 years or younger, underscoring the critical need for device availability for the working-age population.

Simultaneously, the adoption of minimally invasive and robotic-assisted surgical technologies is reshaping the market landscape. Healthcare providers are aggressively investing in advanced infrastructure to perform complex procedures with greater precision and reduced recovery times, thereby driving the procurement of high-value electrosurgical devices and structural heart implants. This modernization is evident in the operational volumes of leading institutions. According to Gulf News, November 2025, in the "574 patients receive world-class cardiac care at Cleveland Clinic Abu Dhabi" report, the facility's Heart, Vascular & Thoracic Institute performed 839 cardiac surgical procedures in 2024, highlighting the substantial utilization of advanced cardiac technologies. Furthermore, broad market growth is supported by expanding hospital networks; according to the Abu Dhabi Media Office, in February 2025, PureHealth recorded an 87 percent year-on-year revenue increase in its hospitals segment, reaching AED 19.7 billion, driven by increased patient volumes and service expansion.

Download Free Sample Report

Key Market Challenges

The high cost of advanced cardiovascular technologies constitutes a significant restraint on the development of the UAE market. Innovative devices, such as next-generation stents and remote rhythm management systems, command premium prices that often exceed standard insurance coverage limits or hospital procurement budgets. This financial barrier forces healthcare providers to restrict the inventory of newer solutions, thereby delaying their widespread integration into standard clinical practice and limiting patient access to effective treatments.

This affordability issue is especially acute given the severe disease burden in the region, which demands extensive resource allocation. According to an article published by the American Heart Association, in 2024, cardiovascular diseases were responsible for approximately 36.7% of all fatalities in the UAE. While this high mortality rate underscores the urgent necessity for superior cardiac care, the prohibitive costs associated with importing and deploying these technologies prevent the market from reaching its full potential, as economic constraints compel a reliance on older, less expensive alternatives despite the critical need for advanced intervention.

Key Market Trends

The Surge in Minimally Invasive TAVR and Catheter-Based Procedures is fundamentally altering treatment paradigms in the UAE, as clinicians increasingly prioritize transcatheter solutions over traditional open-heart surgeries for valve replacements. This transition is driven by the superior clinical outcomes and reduced recovery times associated with catheter-based interventions, prompting leading institutions to dedicate specific resources to structural heart programs. According to Gulf News, November 2025, in the '574 patients receive world-class cardiac care at Cleveland Clinic Abu Dhabi' report, the hospital's Heart, Vascular & Thoracic Institute performed 265 structural heart interventions in 2024, distinct from standard surgical volumes, highlighting the rapid acceleration of these specialized non-invasive procedures.

Simultaneously, the Shift Towards Ambulatory and Outpatient Cardiovascular Care Settings is expanding market reach by decentralizing diagnostic and monitoring services from major hospitals to community-based clinics. Healthcare providers are aggressively developing satellite networks to capture patient demand for routine cardiac management and day-case interventions, thereby alleviating pressure on quaternary centers and improving patient accessibility. According to Burjeel Holdings, March 2025, in the 'FY 2024 MD&A Report', the group achieved an 11 percent year-on-year revenue growth in its cardiology specialty, a performance significantly driven by the strategic ramp-up of its outpatient medical centers and day surgery capabilities.

Segmental Insights

The heart failure segment represents the fastest-growing category in the UAE cardiovascular devices market, primarily driven by the increasing incidence of lifestyle-related conditions such as diabetes and hypertension. These health issues significantly elevate the risk of cardiac complications among the population, creating a strong need for effective intervention. Additionally, the Ministry of Health and Prevention continues to support the adoption of monitoring and support systems to improve patient outcomes. This regulatory focus, combined with broader diagnostic capabilities, ensures that the demand for heart failure management devices remains high compared to other market segments.

Regional Insights

Abu Dhabi stands as the leading region in the UAE Cardiovascular Devices Market, primarily due to its comprehensive healthcare infrastructure and strategic government initiatives. The Department of Health – Abu Dhabi (DoH) drives this dominance by enforcing rigorous quality standards and establishing Centres of Excellence for cardiac care. This regulatory framework encourages the rapid adoption of advanced diagnostic and surgical technologies within local hospitals. Furthermore, consistent public investment in specialized medical facilities attracts global device manufacturers to the emirate. These factors collectively establish Abu Dhabi as the central hub for cardiovascular technology and treatment in the country.

Recent Developments

• In September 2024, Al Qassimi Hospital in Sharjah successfully performed the first implantation of the Esprit BTK Everolimus Eluting Resorbable Scaffold System in the UAE. Developed by Abbott, this dissolvable stent is designed to treat chronic limb-threatening ischemia in arteries below the knee. The procedure marked a significant milestone for cardiovascular care in the country, offering a new therapeutic solution that supports vessel healing before gradually dissolving. The Division Vice President for Abbott’s vascular business in the region stated that this achievement underscores the commitment to bringing cutting-edge medical technologies to patients in the Emirates.
• In May 2024, Boston Scientific inaugurated a new logistics and distribution center in Dubai South to strengthen its supply chain capabilities across the Middle East and Africa. This facility, managed in partnership with a third-party logistics provider, represents a significant expansion of the company's operational infrastructure in the UAE. The center is designed to improve the delivery speed of medical technologies, including cardiovascular devices, to hospitals and patients throughout the region. The Vice President for Growth Emerging Markets at Boston Scientific noted that this investment highlights the growing importance of emerging markets to the global medical device sector.
• In March 2024, GE HealthCare formed a strategic collaboration with the Dar Al Ber Society and the Emirates Resuscitation Council to launch the first mobile cardiac catheterization laboratory in the Middle East. This self-contained mobile unit was introduced in Dubai to provide advanced cardiovascular diagnostic services and minimally invasive procedures to patients in underserved areas. The initiative aligns with the country's national goals to reduce the burden of cardiovascular diseases. The fully equipped facility aims to enhance access to high-quality heart care and reduce mortality rates associated with non-communicable diseases across the region.
• In January 2024, Siemens Healthineers introduced the ACUSON Origin, a dedicated cardiovascular ultrasound system integrated with artificial intelligence, during the Arab Health exhibition in Dubai. The company also unveiled the SOMATOM Pro.Pulse, a dual-source computed tomography scanner designed to make advanced cardiac imaging more accessible to smaller healthcare facilities. These product launches were part of the company's strategy to enhance diagnostic accuracy and improve patient outcomes in the region. The systems aim to support clinicians with real-time insights and streamlined workflows, addressing the growing demand for precision medicine in the management of cardiovascular diseases.

Key Market Players

• Medtronic Meta FZ-LLC
• Abbott Laboratories S.A.
• Terumo UAE
• Philips Healthcare UAE
• Life Companion
• Vasmed UAE
• Life Mate Medical Equipment Trading LLC
• Boston Scientific Corporation
• GE HealthCare
• Siemens Healthineers AG
• Edwards Lifesciences Corporation

By Application	By End User	By Region
Coronary Artery Disease Cardiac Arrhythmia Heart Failure Others	Hospitals & Clinics Diagnostic Centers Others	Dubai Abu Dhabi Sharjah Rest of UAE

Report Scope:

In this report, the UAE Cardiovascular Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• UAE Cardiovascular Devices Market, By Application:

• Coronary Artery Disease
• Cardiac Arrhythmia
• Heart Failure
• Others

• UAE Cardiovascular Devices Market, By End User:

• Hospitals & Clinics
• Diagnostic Centers
• Others

• UAE Cardiovascular Devices Market, By Region:

• Dubai
• Abu Dhabi
• Sharjah
• Rest of UAE